Literature DB >> 17707491

Successful treatment of a giant isolated cerebral mucormycotic (zygomycotic) abscess using endoscopic debridement: case report and therapeutic considerations.

Philippe Metellus1, Mehdi Laghmari, Stéphane Fuentes, Alexandre Eusebio, Tarek Adetchessi, Stéphane Ranque, Corinne Bouvier, Henry Dufour, François Grisoli.   

Abstract

BACKGROUND: Cerebral mucormycosis without rhino-orbital or systemic involvement is an extremely rare condition mostly associated with parenteral drug abuse. CASE DESCRIPTION: We report the case of a 42-year-old woman who presented with hemiparesis of the left side and altered mental status. Neuroradiologic workup demonstrated an inflammatory lesion involving the right basal ganglia. Proton magnetic resonance spectroscopy demonstrated features consistent with a pyogenic abscess. Computed tomography-guided stereotactic biopsy led to the diagnosis of cerebral mucormycosis. Parenteral AMB-L treatment was conducted, but the patient worsened clinically, presenting with a complete hemiplegia, and cerebral magnetic resonance imaging (MRI) scans demonstrated a voluminous abscess formation. Then, under stereotactic guidance, a surgical endoscopic debridement of the abscess cavity associated with the placement of an Ommaya reservoir was performed. Systemic and intralesional treatment with AmB associated with an adjunctive immune therapy was conducted. At 3-year follow-up, the patient had recovered partially from her left hemiplegia, allowing her to walk without help, and cerebral MRI scans showed complete resorption of the abscess.
CONCLUSION: Our good results suggest that surgical endoscopic debridement associated with intravenous and intracavitary antifungal therapy might be valuable in treating voluminous deep-seated mucormycotic lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707491     DOI: 10.1016/j.surneu.2007.02.035

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

1.  A 28-year-old i.v. drug user with bilateral basal ganglia and brainstem lesions.

Authors:  Tanya P Lin; Rebecca Thompson; Bruce Coull
Journal:  Neurology       Date:  2013-02-12       Impact factor: 9.910

2.  Spectrum of zygomycete species identified in clinically significant specimens in the United States.

Authors:  E Alvarez; D A Sutton; J Cano; A W Fothergill; A Stchigel; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

3.  Isolated cerebellar mucormycosis, slowly progressive over 1 year in an immunocompetent patient.

Authors:  Ellen L Air; Achala A Vagal; Ady Kendler; Christopher M McPherson
Journal:  Surg Neurol Int       Date:  2010-12-13

4.  Isolated Cerebral Mucormycosis in Immunocompetent Adults who Inject Drugs: Case Reports and Systematic Review of the Literature.

Authors:  Eric A Meyerowitz; Sarimer Sanchez; Michael K Mansour; Virginia A Triant; Marcia B Goldberg
Journal:  Open Forum Infect Dis       Date:  2020-11-13       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.